CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.
Media Contact: [email protected]
At BIO 2026, industry wrestled with Washington politics, and making AI work better
Jun 25, 2026
Executives talked about strategies to adapt to Trump’s way of governance, and the rising cost of AI
Read More California Life Sciences’ Statement on HHS Clinical Trial Effort
Jun 23, 2026
Read CLS President & CEO Mike Guerra's statement on the Department of Health and Human Services' coordinated effort to restore U.S. leadership in clinical trials.
Read More California: Limitless Possibility Lives Here, For Now.
Jun 22, 2026
It started with a conversation. A biochemist and a venture capitalist, talking about what science could do, for medicine, for business, for people.
Read More California Life Sciences Urges Governor Newsom to Honor Commitment to California Innovation, Restore Full R&D Tax Credit Instead of Raising Taxes
May 14, 2026
California Life Sciences urges Governor Newsom to honor commitment to California innovation and restore full R&D tax credit instead of raising taxes.
Read More California Life Sciences Responds to RAPID Coverage Pathway Announcement
Apr 23, 2026
California Life Sciences (CLS), which represents more than 1,300 pharmaceutical, biotechnology, medical technology, and academic research institutions, responded today to the announcement of the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway, a new initiative from the Centers for Medicare & Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) designed to accelerate Medicare coverage of FDA-authorized Breakthrough Devices.
Read More